These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 28639343)

  • 1. First case of anaphylaxis after botulinum toxin type A injection.
    Moon IJ; Chang SE; Kim SD
    Clin Exp Dermatol; 2017 Oct; 42(7):760-762. PubMed ID: 28639343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Noninvasive monitoring of changes in the structure and function of masseter muscles after the injection of botulinum toxin type A].
    Guo Z; Diao X; Xia W; Liu T; Chen Y; Zheng J; Zhou Z; Yang P; Zhu J
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2016 Nov; 32(6):437-40. PubMed ID: 30067323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abobotulinum toxin A and onabotulinum toxin A for masseteric hypertrophy: a split-face study in 25 Korean patients.
    Lee SH; Wee SH; Kim HJ; Yeo UC; Lee NH; Lee SW; Cho SB
    J Dermatolog Treat; 2013 Apr; 24(2):133-6. PubMed ID: 21888570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of botulinum toxin in masseter muscle hypertrophy for lower face contouring.
    Kundu N; Kothari R; Shah N; Sandhu S; Tripathy DM; Galadari H; Gold MH; Goldman MP; Kassir M; Schepler H; Grabbe S; Goldust M
    J Cosmet Dermatol; 2022 May; 21(5):1849-1856. PubMed ID: 35176198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute visual loss after botulinum toxin A injection in the masseter muscle.
    Chun BY; Kim SY
    Int Ophthalmol; 2018 Jun; 38(3):1339-1342. PubMed ID: 28536763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does Botulinum Toxin Injection into Masseter Muscles Affect Subcutaneous Thickness?
    Park G; Choi YC; Bae JH; Kim ST
    Aesthet Surg J; 2018 Feb; 38(2):192-198. PubMed ID: 29117291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Quantitative analysis based on three-dimensional stereophotogrammetry in the observation of curative effect of botulinum toxin A on masseter hypertrophy].
    Xue Z; Zeng W; Chen Z; Han Y
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2016 Jul; 32(4):272-5. PubMed ID: 30044570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paradoxical bulging of mentalis after botulinum toxin type A injection.
    Yu N; Liu Y; Chen C; Dong R; Yang E; Wang X
    J Cosmet Dermatol; 2020 Jun; 19(6):1290-1293. PubMed ID: 32346978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical lymphadenopathy following botulinum toxin type A injection for masseter hypertrophy: Is it just a coincidence?
    Leng M; Zhao H
    J Cosmet Dermatol; 2022 Oct; 21(10):5264-5265. PubMed ID: 35263487
    [No Abstract]   [Full Text] [Related]  

  • 10. [The use of botulinum toxin type A in masseter muscle hypertrophy: long-term effects and lasting improvement].
    Aydil B; Başaran B; Unsaler S; Süoğlu Y
    Kulak Burun Bogaz Ihtis Derg; 2012; 22(5):249-53. PubMed ID: 22991984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of clinical marking and ultrasound-guided injection of Botulinum type A toxin into the masseter muscles for treating bruxism and its cosmetic effects.
    Quezada-Gaon N; Wortsman X; Peñaloza O; Carrasco JE
    J Cosmet Dermatol; 2016 Sep; 15(3):238-44. PubMed ID: 26799545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aesthetic uses of botulinum toxin A.
    Niamtu J
    J Oral Maxillofac Surg; 1999 Oct; 57(10):1228-33. PubMed ID: 10513870
    [No Abstract]   [Full Text] [Related]  

  • 13. Classification of masseter hypertrophy for tailored botulinum toxin type A treatment.
    Xie Y; Zhou J; Li H; Cheng C; Herrler T; Li Q
    Plast Reconstr Surg; 2014 Aug; 134(2):209e-218e. PubMed ID: 25068343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin type A in the management of masseter muscle hypertrophy.
    Castro WH; Gomez RS; Da Silva Oliveira J; Moura MD; Gomez RS
    J Oral Maxillofac Surg; 2005 Jan; 63(1):20-4. PubMed ID: 15635552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RimabotulinumtoxinB versus OnabotulinumtoxinA in the treatment of masseter hypertrophy: a 24-week double-blind randomized split-face study.
    Lee DH; Jin SP; Cho S; Feneran A; Youn CS; Won CH; Park GH; Kim BW; An J; Chang SE; Lee MW
    Dermatology; 2013; 226(3):227-32. PubMed ID: 23774030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Pilot Study on the Treatment of Posterior Cheek Enlargement in HIV+ Patients With Botulinum Toxin A.
    Scali C; Carruthers A; Malpas D; Humphrey S
    Dermatol Surg; 2015 Nov; 41(11):1300-8. PubMed ID: 26469200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Esotropia following botulinum toxin type A injection for facial wrinkles.
    Lee SK; Jun HJ
    J Cosmet Laser Ther; 2018 Feb; 20(1):50-51. PubMed ID: 28682151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botox® after Botox® - a new approach to treat diplopia secondary to cosmetic botulinic toxin use: case reports.
    Isaac CR; Chalita MR; Pinto LD
    Arq Bras Oftalmol; 2012; 75(3):213-4. PubMed ID: 22872208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Multicenter Phase II Study Evaluating the Safety and Efficacy of Botulax in Asian Patients with Benign Masseteric Hypertrophy.
    Lee JS; Son HS; Kim BJ; Lee YW
    Plast Reconstr Surg; 2024 May; 153(5):910e-918e. PubMed ID: 37335589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower facial remodeling with botulinum toxin type A for the treatment of masseter hypertrophy.
    Klein FH; Brenner FM; Sato MS; Robert FM; Helmer KA
    An Bras Dermatol; 2014; 89(6):878-84. PubMed ID: 25387491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.